SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes
Get Live Data
600.00    -10.00 (-1.64%)
Bid:
598.00
Ask:
600.00
Spread: 2.00 (0.334%)
Market Cap: £726.05m
OXB Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biomedica Share Chart

Oxford Biomedica News

Oxford Biomedica says Sanofi pulling out of haemophilia project
19 Mar 2021

Oxford Biomedica says Sanofi pulling out of haemophilia project

(Sharecast News) - Oxford Biomedica said that Sanofi's decision to terminate collaboration on a haemophilia treatment would have a "negligible" impact...

IN BRIEF: Oxford Biomedica Adds Genetics Professor To Non-Exec Team
3 Feb 2021

IN BRIEF: Oxford Biomedica Adds Genetics Professor To Non-Exec Team

IN BRIEF: Oxford Biomedica Adds Genetics Professor To Non-Exec Team

UPDATE 1-EU holds out for more after AstraZeneca offered 8 mln extra COVID-19 shots
29 Jan 2021

UPDATE 1-EU holds out for more after AstraZeneca offered 8 mln extra COVID-19 shots

* Astra had committed to at least 80 mln shots in Q1* EU funded two UK plants under deal with Astra - sources* Astra says UK has priority for doses pr...

IN BRIEF: Oxford Biomedica's Facility In Oxford Now Formally Opened
18 Jan 2021

IN BRIEF: Oxford Biomedica's Facility In Oxford Now Formally Opened

IN BRIEF: Oxford Biomedica's Facility In Oxford Now Formally Opened

UK BROKER RATINGS SUMMARY: Shore Says Buy Hargreaves; UBS Cuts Next
8 Jan 2021

UK BROKER RATINGS SUMMARY: Shore Says Buy Hargreaves; UBS Cuts Next

UK BROKER RATINGS SUMMARY: Shore Says Buy Hargreaves; UBS Cuts Next

UK's initial AstraZeneca shots will come from Europe, taskforce says
8 Dec 2020

UK's initial AstraZeneca shots will come from Europe, taskforce says

By Alistair SmoutLONDON, Dec 8 (Reuters) - Britain's initial doses of the COVID-19 vaccine candidate developed by AstraZeneca and Oxford University ...

UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell
1 Dec 2020

UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell

UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell

Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development
9 Nov 2020

Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development

Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development